Substituted aminopyridine compounds as EGFR inhibitors
Abstract:
Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
Public/Granted literature
Information query
Patent Agency Ranking
0/0